508 related articles for article (PubMed ID: 27313535)
1. The Influence of Na(+), K(+)-ATPase on Glutamate Signaling in Neurodegenerative Diseases and Senescence.
Kinoshita PF; Leite JA; Orellana AM; Vasconcelos AR; Quintas LE; Kawamoto EM; Scavone C
Front Physiol; 2016; 7():195. PubMed ID: 27313535
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Pathology of the α3 Na(+)/K(+)-ATPase Ion Pump in Neurological Disorders; Lessons from Animal Models.
Holm TH; Lykke-Hartmann K
Front Physiol; 2016; 7():209. PubMed ID: 27378932
[TBL] [Abstract][Full Text] [Related]
3. ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria.
Vetro A; Nielsen HN; Holm R; Hevner RF; Parrini E; Powis Z; Møller RS; Bellan C; Simonati A; Lesca G; Helbig KL; Palmer EE; Mei D; Ballardini E; Van Haeringen A; Syrbe S; Leuzzi V; Cioni G; Curry CJ; Costain G; Santucci M; Chong K; Mancini GMS; Clayton-Smith J; Bigoni S; Scheffer IE; Dobyns WB; Vilsen B; Guerrini R;
Brain; 2021 Jun; 144(5):1435-1450. PubMed ID: 33880529
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism ATP1A3 mutations reveals functional deficits, which do not correlate with disease severity.
Lazarov E; Hillebrand M; Schröder S; Ternka K; Hofhuis J; Ohlenbusch A; Barrantes-Freer A; Pardo LA; Fruergaard MU; Nissen P; Brockmann K; Gärtner J; Rosewich H
Neurobiol Dis; 2020 Sep; 143():105012. PubMed ID: 32653672
[TBL] [Abstract][Full Text] [Related]
5. The expanding spectrum of neurological phenotypes in children with ATP1A3 mutations, Alternating Hemiplegia of Childhood, Rapid-onset Dystonia-Parkinsonism, CAPOS and beyond.
Sweney MT; Newcomb TM; Swoboda KJ
Pediatr Neurol; 2015 Jan; 52(1):56-64. PubMed ID: 25447930
[TBL] [Abstract][Full Text] [Related]
6. Zebrafish as a novel model to assess Na+/K(+)-ATPase-related neurological disorders.
Doğanli C; Oxvig C; Lykke-Hartmann K
Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2774-87. PubMed ID: 24091024
[TBL] [Abstract][Full Text] [Related]
7. Insights into the Pathology of the α2-Na(+)/K(+)-ATPase in Neurological Disorders; Lessons from Animal Models.
Isaksen TJ; Lykke-Hartmann K
Front Physiol; 2016; 7():161. PubMed ID: 27199775
[TBL] [Abstract][Full Text] [Related]
8. ATP1A3-related phenotypes in Chinese children: AHC, CAPOS, and RECA.
Huang D; Song X; Ma J; Li X; Guo Y; Li M; Luo H; Fang Z; Yang C; Xie L; Jiang L
Eur J Pediatr; 2023 Feb; 182(2):825-836. PubMed ID: 36484864
[TBL] [Abstract][Full Text] [Related]
9. Influence of Nitric Oxide-Cyclic GMP and Oxidative STRESS on Amyloid-β Peptide Induced Decrease of Na,K-ATPase Activity in Rat Hippocampal Slices.
Kawamoto EM; Cararo-Lopes MM; Kinoshita PF; Quintas LEM; Lima LS; Andreotti DZ; Scavone C
J Membr Biol; 2021 Dec; 254(5-6):463-473. PubMed ID: 34327545
[TBL] [Abstract][Full Text] [Related]
10. Relationship between intracellular Na+ concentration and reduced Na+ affinity in Na+,K+-ATPase mutants causing neurological disease.
Toustrup-Jensen MS; Einholm AP; Schack VR; Nielsen HN; Holm R; Sobrido MJ; Andersen JP; Clausen T; Vilsen B
J Biol Chem; 2014 Feb; 289(6):3186-97. PubMed ID: 24356962
[TBL] [Abstract][Full Text] [Related]
11. Genetically altered animal models for ATP1A3-related disorders.
Ng HWY; Ogbeta JA; Clapcote SJ
Dis Model Mech; 2021 Oct; 14(10):. PubMed ID: 34612482
[TBL] [Abstract][Full Text] [Related]
12. Region- and neuronal-subtype-specific expression of Na,K-ATPase alpha and beta subunit isoforms in the mouse brain.
Murata K; Kinoshita T; Ishikawa T; Kuroda K; Hoshi M; Fukazawa Y
J Comp Neurol; 2020 Nov; 528(16):2654-2678. PubMed ID: 32301109
[TBL] [Abstract][Full Text] [Related]
13. Relapsing encephalopathy with cerebellar ataxia related to an ATP1A3 mutation.
Dard R; Mignot C; Durr A; Lesca G; Sanlaville D; Roze E; Mochel F
Dev Med Child Neurol; 2015 Dec; 57(12):1183-6. PubMed ID: 26400718
[TBL] [Abstract][Full Text] [Related]
14. The CAPOS mutation in ATP1A3 alters Na/K-ATPase function and results in auditory neuropathy which has implications for management.
Tranebjærg L; Strenzke N; Lindholm S; Rendtorff ND; Poulsen H; Khandelia H; Kopec W; Lyngbye TJB; Hamel C; Delettre C; Bocquet B; Bille M; Owen HH; Bek T; Jensen H; Østergaard K; Möller C; Luxon L; Carr L; Wilson L; Rajput K; Sirimanna T; Harrop-Griffiths K; Rahman S; Vona B; Doll J; Haaf T; Bartsch O; Rosewich H; Moser T; Bitner-Glindzicz M
Hum Genet; 2018 Feb; 137(2):111-127. PubMed ID: 29305691
[TBL] [Abstract][Full Text] [Related]
15. ATP1A3-Related Disorders: An Ever-Expanding Clinical Spectrum.
Salles PA; Mata IF; Brünger T; Lal D; Fernandez HH
Front Neurol; 2021; 12():637890. PubMed ID: 33868146
[TBL] [Abstract][Full Text] [Related]
16. Decreased content of ascorbic acid (vitamin C) in the brain of knockout mouse models of Na+,K+-ATPase-related neurologic disorders.
Ikeda K; Tienda AA; Harrison FE; Kawakami K
PLoS One; 2021; 16(2):e0246678. PubMed ID: 33544780
[TBL] [Abstract][Full Text] [Related]
17. De novo p.Arg756Cys mutation of ATP1A3 causes an atypical form of alternating hemiplegia of childhood with prolonged paralysis and choreoathetosis.
Kanemasa H; Fukai R; Sakai Y; Torio M; Miyake N; Lee S; Ono H; Akamine S; Nishiyama K; Sanefuji M; Ishizaki Y; Torisu H; Saitsu H; Matsumoto N; Hara T
BMC Neurol; 2016 Sep; 16():174. PubMed ID: 27634470
[TBL] [Abstract][Full Text] [Related]
18. Managing Brain Extracellular K(+) during Neuronal Activity: The Physiological Role of the Na(+)/K(+)-ATPase Subunit Isoforms.
Larsen BR; Stoica A; MacAulay N
Front Physiol; 2016; 7():141. PubMed ID: 27148079
[TBL] [Abstract][Full Text] [Related]
19. Beyond Dystonia-Parkinsonism: Chorea and Ataxia with ATP1A3 Mutations.
de Gusmao CM; Dy M; Sharma N
Mov Disord Clin Pract; 2016; 3(4):402-404. PubMed ID: 30363590
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
